NEPHCURE KIDNEY INTERNATIONAL
Saving Kidneys. Saving Lives.
Programs and results
What we aim to solve
Working with all stakeholders to bring treatments for Nephrotic Syndrome and FSGS to the market.
Our programs
What are the organization's current programs, how do they measure success, and who do the programs serve?
Research Acceleration
NephCure is working to identify all patients and educate them on clinical trials.
Where we work
Affiliations & memberships
National Organization for Rare Disorders - Member 2018
External reviews

Videos
Our results
How does this organization measure their results? It's a hard question but an important one.
Number of patients positively affected by educating clinicians
This metric is no longer tracked.Totals By Year
Type of Metric
Output - describing our activities and reach
Direction of Success
Increasing
Context Notes
These numbers are estimated by how many clinicians attended our educational offerings and their responses to our surveys.
Goals & Strategy
Learn about the organization's key goals, strategies, capabilities, and progress.
Charting impact
Four powerful questions that require reflection about what really matters - results.
What is the organization aiming to accomplish?
NephCure aims to accelerate research into treatments for FSGS and Nephrotic Syndrome.
What are the organization's key strategies for making this happen?
NephCure is working to identify all NS/FSGS patients and educate them about clinical trials.
What are the organization's capabilities for doing this?
NephCure is the only patient advocacy group serving this population. We know the doctors who treat these patients and many of the patients already.
What have they accomplished so far and what's next?
We have partnered with multiple (upwards of 20) pharmaceutical and biotech companies to help recruit for upcoming trials.
Financials
Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more
about GuideStar Pro.
Operations
The people, governance practices, and partners that make the organization tick.
Connect with nonprofit leaders
SubscribeBuild relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.
Connect with nonprofit leaders
SubscribeBuild relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.
NEPHCURE KIDNEY INTERNATIONAL
Board of directorsas of 02/22/2022
Irv Smokler
No affiliation
Irving Smokler
No Affiliation
Ron Cohen
No Affiliation
Michael Levine
No Affiliation
Andrew Silverman
No Affiliation
Carol Smokler
No Affiliation
Elaine Kamil
No Affiliation
William Smoyer
No Affiliation
David Kershaw
No Affiliation
Kathleen Broderick
No Affiliation
Jim Duquette
No Affiliation
Scott Goldstein
No Affiliation
Sarretta McDonough
No Affiliation
John Roy
No Affiliation
Jennifer Geisser Siegel
No Affiliation
Manu Varma
No Affiliation
Chris Whitney
Mark Winward
Steve Hollomon
Kirk Campbell
Laurel Damashek
Charles Davis
Kevin Mott
Rebecca Oag
Joshua Roy
Christopher Windisch
Martin Zimmerman
Board leadership practices
GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.
-
Ethics and transparency
Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes